Evidence map›Paper›PMID 40329645›Full record

ArticleAnalytical chemistry2025

Field-Portable Technology for Illicit Drug Discrimination via Deep Learning of Hybridized Reflectance/Fluorescence Spectroscopic Fingerprints.

Alexander Power, Matthew Gardner, Rachael Andrews, Gyles Cozier, Ranjeet Kumar, Tom P Freeman, Ian S Blagbrough, Peter Sunderland, Jennifer Scott, Anca Frinculescu and 10 more

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alexander PowerDepartment of Computer Science, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0001-5348-7068
Matthew GardnerDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.
Rachael AndrewsDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0002-7836-036X
Gyles CozierDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.
Ranjeet KumarDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.
Tom P FreemanDepartment of Psychology, University of Bath, Bath BA2 7AY, U.K.
Ian S BlagbroughDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0003-0307-4999
Peter SunderlandDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.
Jennifer ScottCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol BS8 2PS, U.K.
Anca FrinculescuTICTAC Communications Ltd., St. George's University of London, Room 1.159 Jenner Wing, Cranmer Terrace, London SW17 0RE, U.K.
Trevor ShineTICTAC Communications Ltd., St. George's University of London, Room 1.159 Jenner Wing, Cranmer Terrace, London SW17 0RE, U.K.
Gillian TaylorSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, U.K.
Caitlyn NormanLeverhulme Research Centre for Forensic Science, University of Dundee, Dundee DD1 4HN, U.K.ORCID 0000-0003-2322-0367
Hervé MénardLeverhulme Research Centre for Forensic Science, University of Dundee, Dundee DD1 4HN, U.K.
Niamh N DaéidLeverhulme Research Centre for Forensic Science, University of Dundee, Dundee DD1 4HN, U.K.
Oliver B SutcliffeMANchester DRug Analysis & Knowledge Exchange (MANDRAKE), Department of Natural Sciences, Manchester Metropolitan University, Manchester M1 5GD, U.K.ORCID 0000-0003-3781-7754
Stephen M HusbandsDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0002-9928-6322
Richard W BowmanSchool of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, U.K.ORCID 0000-0002-1531-8199
Tom S F HainesDepartment of Computer Science, University of Bath, Bath BA2 7AY, U.K.
Christopher R PudneyDepartment of Life Sciences, University of Bath, Bath BA2 7AY, U.K.ORCID 0000-0001-6211-0086

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel psychoactive substances (NPS) pose one of the greatest challenges across the illicit drug landscape. They can be highly potent, and coupled with rapid changes in structure, tracking and identifying these drugs is difficult and presents users with a "Russian roulette" if used. Benzodiazepines, synthetic opioids, synthetic cannabinoids, and synthetic cathinones account for the majority of NPS-related deaths and harm. Detecting these drugs with existing field-portable technologies is challenging and has hampered the development of community harm reduction services and interventions. Herein, we demonstrate that hybridizing fluorescence and reflectance spectroscopies can accurately identify NPS and provide concentration information with a focus on benzodiazepines and nitazenes. The discrimination is achieved through a deep learning algorithm trained on a library of preprocessed spectral data. We demonstrate the potential for these measurements to be made using a low-cost, portable device that requires minimal user training. Using this device, we demonstrate the discrimination of 11 benzodiazepines from "street" tablets that include bulking agents and other excipients. We show the detection of complex mixtures of multiple drugs, with the key example of nitazene + benzodiazepine (metonitazene + bromazolam), fentanyl + xylazine, and heroin + nitazene (etonitazene) combinations. These samples represent current drug trends and are associated with drug-related deaths. When combined with the implementation of detection technology in a portable device, these data point to the immediate potential to support harm reduction work in community-based settings. Finally, we demonstrate that the approach may be generalized to other drug classes outside NPS discrimination.

Indexed as

Deep LearningIllicit DrugsBenzodiazepinesSpectrometry, FluorescenceBenzodiazepinesIllicit Drugs

Identifiers

PMID40329645
PMCPMC12096345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.